Published in J Chromatogr on November 26, 1975
Partial metabolic clearances as determinants of the oral bioavailability of propranolol. Br J Clin Pharmacol (1986) 0.84
Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy. Br J Clin Pharmacol (1979) 0.80
Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9- and 10-year-old girls. J Am Diet Assoc (1994) 2.30
A prospective longitudinal study of social, psychological and obstetric factors in pregnancy: response rates and demographic characteristics of the 8556 respondents. Br J Obstet Gynaecol (1989) 2.27
Ethics approval for research in medical education. Med Educ (2001) 1.96
The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin Pharmacol Ther (1978) 1.51
Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet (1999) 1.50
Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47
Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation (1984) 1.41
Neural control of the lower urinary tract: peripheral and spinal mechanisms. Neurourol Urodyn (2010) 1.35
The mental health of women 6 months after they give birth to an unwanted baby: a longitudinal study. Soc Sci Med (1991) 1.33
Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis. Clin Pharmacol Ther (1986) 1.31
Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem Pharmacol (1999) 1.25
Unemployment and reproductive outcome. An Australian study. Br J Obstet Gynaecol (1989) 1.25
Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum (1998) 1.24
Hepatitis-associated antigen (Australia antigen) in Massachusetts blood donors. N Engl J Med (1971) 1.23
GLC determination of propranolol, other beta-blocking drugs, and metabolites in biological fluids and tissues. J Pharm Sci (1974) 1.22
More on medical student stress. Med Educ (2001) 1.22
Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit Care Med (1990) 1.22
Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet (2001) 1.21
Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation (1984) 1.18
Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem Pharmacol (1998) 1.18
Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clin Infect Dis (1992) 1.18
Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion. N Engl J Med (1983) 1.18
Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. J Pharmacol Exp Ther (1972) 1.17
A process evaluation of medical ethics education in the first year of a new medical curriculum. Med Educ (2000) 1.16
Improving the health of people with intellectual disabilities: outcomes of a health screening programme after 1 year. J Intellect Disabil Res (2006) 1.16
Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate (2000) 1.16
Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther (2000) 1.14
Food iron and lead absorption in humans. Am J Clin Nutr (1986) 1.13
General practitioners' educational needs in intellectual disability health. J Intellect Disabil Res (2004) 1.13
Impact of a new course on students' potential behaviour on encountering ethical dilemmas. Med Educ (2001) 1.12
Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Drug Metab Dispos (1996) 1.11
The management of involuntary childlessness. Br J Gen Pract (1997) 1.10
Extensive binding of the bioflavonoid quercetin to human plasma proteins. J Pharm Pharmacol (1998) 1.10
Naphthoxylactic acid after single and long-term doses of propranolol. Clin Pharmacol Ther (1979) 1.10
Review of brucellosis cases from laboratory exposures in the United States in 2008 to 2011 and improved strategies for disease prevention. J Clin Microbiol (2013) 1.10
Social class, religion and contraceptive failure in a sample of pregnant women in Brisbane. Community Health Stud (1984) 1.09
N-nitroso-compound impurities in herbicide formulations. J Agric Food Chem (1977) 1.08
Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm Res (2001) 1.06
Pancreatic enzyme supplements in cystic fibrosis. Lancet (1992) 1.05
Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. Clin Pharmacol Ther (1989) 1.05
Out-patient parenteral antimicrobial therapy--a viable option for the management of cutaneous leishmaniasis. QJM (1999) 1.04
Comparison between broad-band ultrasound attenuation of the calcaneum and total body bone mineral density in children. Acta Paediatr (1996) 1.03
Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab Dispos (1998) 1.02
Newborn brachial plexus injuries: The twisting and extension of the fetal head as contributing causes. J Obstet Gynaecol (2008) 1.02
A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. Science (1992) 1.02
Assessment of a simple scoring system applied to a screening questionnaire of asthma in children aged 5-15 yrs. Eur Respir J (1999) 1.01
Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther (2000) 1.01
Combined effect of amphotericin B and rifampin on Candida species. Antimicrob Agents Chemother (1980) 1.01
Adults with intellectual disabilities: prevalence, incidence and remission of self-injurious behaviour, and related factors. J Intellect Disabil Res (2008) 1.01
Stereoselective binding of propranolol to human plasma, alpha 1-acid glycoprotein, and albumin. Clin Pharmacol Ther (1983) 1.01
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol. Clin Pharmacol Ther (1980) 1.00
Neighbourhood deprivation, health inequalities and service access by adults with intellectual disabilities: a cross-sectional study. J Intellect Disabil Res (2011) 1.00
Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation. Pharm Res (2001) 1.00
Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein. Res Commun Chem Pathol Pharmacol (1993) 1.00
Cost estimation of a health-check intervention for adults with intellectual disabilities in the UK. J Intellect Disabil Res (2008) 0.99
Information control and the exercise of power in the obstetrical encounter. Soc Sci Med (1983) 0.99
Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica (2006) 0.99
Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol (2002) 0.98
Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolites. Clin Pharmacol Ther (1981) 0.98
Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica (1999) 0.97
Adults with intellectual disabilities: prevalence, incidence and remission of aggressive behaviour and related factors. J Intellect Disabil Res (2008) 0.96
Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism. J Pharm Pharmacol (1999) 0.95
Acetylation of spermidine and spermine by rat liver and kidney chromatin. Arch Biochem Biophys (1977) 0.95
Colposcopy and cervical cryotherapy. Feasible additions to the primary care physician's office practice. Postgrad Med (1987) 0.95
Socioeconomic disadvantage and child morbidity: an Australian longitudinal study. Soc Sci Med (1993) 0.95
Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol (1998) 0.95
Stereoselective sulphate conjugation of fenoterol by human phenolsulphotransferases. Xenobiotica (1997) 0.94
Non-invasive measurement of cardiac output by a single breath constant expiratory technique. Thorax (1984) 0.93
Galactorrhea induced by paroxetine. Can J Psychiatry (2001) 0.93
The omega-3 story: nutritional prevention of preterm birth and other adverse pregnancy outcomes. Obstet Gynecol Surv (2001) 0.93
Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. Br J Clin Pharmacol (1993) 0.93
Serum digitalis and arrhythmia in patients undergoing cardiopulmonary bypass. Circulation (1973) 0.93
Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells. Pharm Res (2000) 0.93
Exercise-induced increments in plasma levels of propranolol and noradrenaline. Br J Clin Pharmacol (1983) 0.92
Quantitative account of propranolol metabolism in urine of normal man. Drug Metab Dispos (1985) 0.92
Placental localization. A comparison between ultrasonic compound B scanning and radioisotope scanning. Am J Obstet Gynecol (1969) 0.92
Identification of the unusual polyamines 3,3'-diaminodipropylamine and N,N'-bis(3-aminoproply)-1,3-propanediamine in the white shrimp Penaeus setiferus. Biochem Biophys Res Commun (1977) 0.91
N-Nitrosodiethanolamine in synthetic cutting fluids: a part-per-hundred impurity. Science (1977) 0.91
Child developmental delay and socio-economic disadvantage in Australia: a longitudinal study. Soc Sci Med (1992) 0.90
Injuries, falls and accidents among adults with intellectual disabilities. Prospective cohort study. J Intellect Disabil Res (2010) 0.90
Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. J Steroid Biochem Mol Biol (2000) 0.90
Stereoselective clearance and distribution of intravenous propranolol. Clin Pharmacol Ther (1984) 0.90
Grandmultiparity--not to be feared? An analysis of grandmultiparous women receiving modern antenatal care. Int J Gynaecol Obstet (1994) 0.90
Coupling mechanism of an EMAT. Ultrasonics (2006) 0.89
Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br J Clin Pharmacol (1996) 0.89
Psychosocial adjustment to pelvic exenteration. Gynecol Oncol (1975) 0.89
An evaluation of fructosamine estimation in screening for gestational diabetes mellitus. Diabet Med (1995) 0.89
S-adenosyl-L-methionine: transcellular transport and uptake by Caco-2 cells and hepatocytes. J Pharm Pharmacol (2005) 0.89
A comparison of obstetric morbidity and management between clinic and private patients. Aust N Z J Obstet Gynaecol (1979) 0.88
Biologic determinants of propranolol disposition: results from 1308 patients in the Beta-Blocker Heart Attack Trial. Clin Pharmacol Ther (1985) 0.88
Extensive and saturable accumulation of paclitaxel by the human platelet. Cancer Chemother Pharmacol (1995) 0.88
Rethinking the military family syndrome. Am J Psychiatry (1981) 0.88
Maternal smoking and respiratory distress syndrome. Am J Obstet Gynecol (1983) 0.87
Poor antenatal attendance and obstetric performance. Aust N Z J Obstet Gynaecol (1980) 0.87
Hep G2 cell line as a human model for sulphate conjugation of drugs. Xenobiotica (1992) 0.87
Surveillance of occupational skin disease using the Supplementary Data System. Am J Ind Med (1988) 0.87
Dystrophic neurite formation associated with age-related beta amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology. Exp Neurol (1996) 0.87
Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique. Res Commun Chem Pathol Pharmacol (1979) 0.87
Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2. Res Commun Mol Pathol Pharmacol (1999) 0.87
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer. Br J Cancer (2009) 0.87